Table 4.
Sildenafil | Placebo | P valuea | |
---|---|---|---|
% Change in FVR | % Change in FVR | ||
NE | |||
48 pmol/min | +24±7 | +22±7 | 0.68 |
480 pmol/min | +64±15 | +56±14 | |
ADEN | |||
30 mcg/min | −55±5 | −56±5 | 0.67 |
300 mcg/min | −80±2 | −78±2 | |
ISO | |||
25ng/min | −52±5 | −50±4 | 0.47 |
250ng/min | −77±3 | −72±3 |
Abbreviation: FVR, forearm vascular resistance.
aAnalysis of variance: Group × dose interaction (group = sildenafil or placebo).